DFDA

Cephalexin

Treatment for Cellulitis

Typical Dosage: 250-500mg orally every 6-12 hours

Effectiveness
88%
Safety Score
70%
Clinical Trials
7
Participants
50K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
250-500mg orally every 6-12 hours
Time to Effect
1-2 days
Treatment Duration
7 days
Evidence Quality
HIGH
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$15
Monitoring:$125
Side Effect Mgmt:$10
Total Annual:$150
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0.05
Outcome-Based Costs
Cost per Responder
$166.67
Cost per Remission
$176.47
Prescription Access Economics
Annual Societal Loss per Patient
$1,730
Cost of prescription-only barriers (visits, time, admin, price premium)
Physician Visit Cost
$150/year
Time Cost
$50/year
Travel + wait time
Insurance Admin Cost
$20/year
Prior auth, claims
Rx Price
$15/year
Potential OTC Price
$5/year
Estimated if OTC available
Early Treatment Benefit
+0.01 QALYs
From faster OTC access
Risk Assessment
Misuse Risk
HIGH
Missed Diagnosis Risk
MODERATE
Cephalexin Outcomes

for Cellulitis

Efficacy Outcomes
Overall Effectiveness
+88%
Response Rate
+90%
Remission Rate
+85%
Common Side Effects
Nausea
+5%
Diarrhea
+8%
Vomiting
+2%
Rash
+1%

Sources:

tandfonline.com
impactfactor.org
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
1 active trial recruiting for Cephalexin in Cellulitis

High-dose Cephalexin for Cellulitis (HI-DOCC)

NCT05852262ENROLLING BY INVITATIONPHASE4
View Study
446 participants
INTERVENTIONAL
Calgary, Canada +9 more
Started: Aug 30, 2023
Completed Clinical Trials
6 completed trials for Cephalexin in Cellulitis

High-dose vs. Standard-dose Cephalexin for Cellulitis

NCT04471246COMPLETEDPHASE4
View Study
69 participants
INTERVENTIONAL
Ottawa, Canada
Started: Aug 16, 2021

Study of New Antibiotic Regimen for the Treatment of Uncomplicated Cellulitis in Emergency Department Patients

NCT00676130COMPLETEDNA
View Study
153 participants
INTERVENTIONAL
Boston, United States +2 more
Started: May 1, 2007

Comparison of Intravenous Cefazolin Plus Oral Probenecid With Oral Cephalexin for the Treatment of Cellulitis

NCT01029782COMPLETEDPHASE2
View Study
206 participants
INTERVENTIONAL
Kelowna, Canada +1 more
Started: May 1, 2010

Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections

NCT00352612COMPLETEDPHASE4
View Study
200 participants
INTERVENTIONAL
Baltimore, United States
Started: Sep 1, 2006

A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderate Uncomplicated Skin Infections

NCT00234949COMPLETEDPHASE4
View Study
380 participants
INTERVENTIONAL
Started: Mar 1, 2005

Effective Antibiotic Treatment of MRSA

NCT00388310COMPLETEDNA
View Study
33 participants
INTERVENTIONAL
Newark, United States
Started: Feb 1, 2006